These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 9549956)

  • 21. Buspirone for aggression.
    Quiason N; Ward D; Kitchen T
    J Am Acad Child Adolesc Psychiatry; 1991 Nov; 30(6):1026. PubMed ID: 1757432
    [No Abstract]   [Full Text] [Related]  

  • 22. Electrocardiographic screening in children with attention-deficit hyperactivity disorder.
    Mahle WT; Hebson C; Strieper MJ
    Am J Cardiol; 2009 Nov; 104(9):1296-9. PubMed ID: 19840580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between hospitalization for pharmaceutical ingestion and attention deficit disorder in children aged 5 to 9 years old.
    Hariharan S; Pomerantz W
    Clin Pediatr (Phila); 2008 Jan; 47(1):15-20. PubMed ID: 17641117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ropinirole in a child with attention-deficit hyperactivity disorder and restless legs syndrome.
    Konofal E; Arnulf I; Lecendreux M; Mouren MC
    Pediatr Neurol; 2005 May; 32(5):350-1. PubMed ID: 15866437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Buspirone treatment for apneustic breathing in brain stem infarct.
    El-Khatib MF; Kiwan RA; Jamaleddine GW
    Respir Care; 2003 Oct; 48(10):956-8. PubMed ID: 14525632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of adjustment disorder with anxiety: efficacy and tolerance of etifoxine in a double-blind controlled study].
    Servant D; Graziani PL; Moyse D; Parquet PJ
    Encephale; 1998; 24(6):569-74. PubMed ID: 9949940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind trial of bupropion in children with attention deficit disorder.
    Casat CD; Pleasants DZ; Van Wyck Fleet J
    Psychopharmacol Bull; 1987; 23(1):120-2. PubMed ID: 3110853
    [No Abstract]   [Full Text] [Related]  

  • 28. The efficacy of combined estrogen and buspirone treatment in olivopontocerebellar atrophy.
    Heo JH; Lee ST; Chu K; Kim M
    J Neurol Sci; 2008 Aug; 271(1-2):87-90. PubMed ID: 18466925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anxiolytics, adrenergic agents, and naltrexone.
    Riddle MA; Bernstein GA; Cook EH; Leonard HL; March JS; Swanson JM
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):546-56. PubMed ID: 10230186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional deficits in basal ganglia of children with attention-deficit/hyperactivity disorder shown with functional magnetic resonance imaging relaxometry.
    Teicher MH; Anderson CM; Polcari A; Glod CA; Maas LC; Renshaw PF
    Nat Med; 2000 Apr; 6(4):470-3. PubMed ID: 10742158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematologic and blood biochemistry monitoring during methylphenidate treatment in children with attention-deficit/hyperactivity disorder: 2-year, open-label study results.
    Wigal SB; Wilens TE; Wolraich M; Lerner M
    Pediatrics; 2007 Jul; 120(1):e120-8. PubMed ID: 17548486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Children with attention deficit hyperactivity disorder and attendance at hospital.
    Hoare P; Beattie T
    Eur J Emerg Med; 2003 Jun; 10(2):98-100. PubMed ID: 12789063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of buspirone on the development of an experimental depressive syndrome in rats, caused by systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)].
    Krupina NA; Kryzhanovskiĭ GN; Orlova IN; Iordanskaia TE
    Biull Eksp Biol Med; 1996 May; 121(5):489-94. PubMed ID: 8744118
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy of methylphenidate among mentally retarded children with attention deficit hyperactivity disorder.
    Handen BL; Breaux AM; Gosling A; Ploof DL; Feldman H
    Pediatrics; 1990 Dec; 86(6):922-30. PubMed ID: 2135682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-regulation of slow cortical potentials: a new treatment for children with attention-deficit/hyperactivity disorder.
    Strehl U; Leins U; Goth G; Klinger C; Hinterberger T; Birbaumer N
    Pediatrics; 2006 Nov; 118(5):e1530-40. PubMed ID: 17060480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of two rating scales for attention-deficit hyperactivity disorder diagnosis in Colombian children.
    Pineda DA; Aguirre DC; Garcia MA; Lopera FJ; Palacio LG; Kamphaus RW
    Pediatr Neurol; 2005 Jul; 33(1):15-25. PubMed ID: 15993319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Exercise on Cognitive Performance in Children and Adolescents with ADHD: Potential Mechanisms and Evidence-based Recommendations.
    Christiansen L; Beck MM; Bilenberg N; Wienecke J; Astrup A; Lundbye-Jensen J
    J Clin Med; 2019 Jun; 8(6):. PubMed ID: 31212854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Buspirone in Children and Adolescents with Anxiety: A Review and Bayesian Analysis of Abandoned Randomized Controlled Trials.
    Strawn JR; Mills JA; Cornwall GJ; Mossman SA; Varney ST; Keeshin BR; Croarkin PE
    J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):2-9. PubMed ID: 28846022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Buspirone versus methylphenidate in the treatment of attention deficit hyperactivity disorder: a double-blind and randomized trial.
    Davari-Ashtiani R; Shahrbabaki ME; Razjouyan K; Amini H; Mazhabdar H
    Child Psychiatry Hum Dev; 2010 Dec; 41(6):641-8. PubMed ID: 20517641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-stimulant medications in the treatment of ADHD.
    Banaschewski T; Roessner V; Dittmann RW; Santosh PJ; Rothenberger A
    Eur Child Adolesc Psychiatry; 2004; 13 Suppl 1():I102-16. PubMed ID: 15322961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.